Cargando…
Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease caused by mutations in hematopoietic stem cells leading to pancytopenia and a predisposition for thromboembolic events. In pregnancy, these manifestations can be amplified, leading to increased neonatal and maternal morbidity and mortality....
Autores principales: | Fassett, Michael J., Hernandez Lopez, Adrian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903290/ https://www.ncbi.nlm.nih.gov/pubmed/33665137 http://dx.doi.org/10.1016/j.crwh.2021.e00294 |
Ejemplares similares
-
The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
por: Kelly, Richard, et al.
Publicado: (2009) -
Eculizumab-Related Abortion in a Woman with Paroxysmal Nocturnal Hemoglobinuria: A Case Report
por: Rodríguez-Ferreras, Adrián, et al.
Publicado: (2019) -
Atypical presentation of paroxysmal nocturnal hemoglobinuria treated by eculizumab: A case report
por: Quinquenel, Anne, et al.
Publicado: (2017) -
Eculizumab application during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: A case report with review of the literature
por: Lauritsch‐Hernandez, Lisa Sophie, et al.
Publicado: (2018) -
Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
por: Quist, S. W., et al.
Publicado: (2023)